Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

Nature Neuroscience

Volumn 2, Issue 12, 1999, Pages 1137-1140

  Piccini, Paola ^a   Brooks, David J ^a   Björklund, Anders ^b   Gunn, Roger N ^a   Grasby, Paul M ^a   Rimoldi, Ornella ^a   Brundin, Patrik ^b   Hagell, Peter ^b,c   Rehncrona, Stig ^c   Widner, Håkan ^b,c   Lindvall, Olle ^b,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; RACLOPRIDE;

AGED; ARTICLE; BRAIN TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; EMBRYO; HUMAN; HUMAN TISSUE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SYNAPSE;

AGED; BINDING SITES; BRAIN TISSUE TRANSPLANTATION; CAUDATE NUCLEUS; DOPAMINE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NEURONS; PARKINSON DISEASE; PUTAMEN; RACLOPRIDE; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA; SYNAPSES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0033491121     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/16060     Document Type: Article

References (20)

1. Brundin, P., Duan, W.-M. & Sauer, H. in Functional Neural Transplantation (eds. Dunnett, S. B. & Björklund, A.) 9-46 (Raven, New York, 1994).
2. Annett, L. E. in Functional Neural Transplantation (eds. Dunnett, S. B. & Björklund, A.) 71-102 (Raven, New York, 1994).
3. Olanow, C. W., Kordower, J. H. & Freeman, T. B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102-109 (1996).
4. Lindvall, O. Cerebral implantation in movement disorders: State of the art. Mov. Disord. 14, 201-205 (1999).
5. Kordower, J. H. et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118-1124 (1995).
6. Kordower, J. H. et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13, 383-393 (1998).
7. 11C]Raclopride binding with continuous infusion. J. Cereb. Blood Flow Metab. 17, 437-447 (1997).
8. Koepp, M. J. et al. Evidence for striatal dopamine release during a videogame. Nature 393, 266-268 (1998).
9. Lindvall, O. et al. Transplantation of fetal dopamine neurons in Parkinson's disease: 1-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31, 155-165 (1992).
10. Lindvall, O. et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35, 172-180 (1994).
11. Wenning, G. K. et al. Short-and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42, 95-107 (1997).
12. Seeman, P. et al. Human brain D1 and D2 receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases. Neuropsychopharmacology 1, 5-15 (1987).
13. Rinne, U. K. et al. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Mov. Disord. 5, 55-59 (1990).
14. Sawle, G. V., Playford, E. D., Brooks, D. J., Quinn, N. & Frackowiak, R. S. J. Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism. Brain 116, 853-867 (1993).
15. 11C]-raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: influence of L-dopa and lisuride therapy on striatal dopamine D2 receptors. Neurology 44, 1325-1329 (1994).
16. Elsworth, J. H. et al. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study. Brain Res. 795, 55-62 (1998).
17. Laruelle, M. et al. Microdialysis and SPECT measurements of amphetamine-induced release in nonhuman primates. Synapse 25, 1-14 (1997).
18. Gunn, R. N., Lammertsma, A. A., Hume, S. P. & Cunningham, V. J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6, 279-287 (1997).
19. Studholme, C., Derek, L. G. & Hawkes D. J. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med. Phys. 24, 25-35 (1997).
20. 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann. Neurol. 28, 547-555 (1990).